Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

NCT01259219 is registered in ClinicalTrials.gov with Harriet Shezi Children's Clinic as lead sponsor.

NCT NCT01259219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01259219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Lead sponsor
Harriet Shezi Children's Clinic
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2010
Completion date
June 30, 2012
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

children with confirmed hiv infection, receiving art regimen containing 2 nrtis + lpv/rtv at standard dose, successfully completed tb treatment in the past 2 to 6 weeks of enrollment